Will my OMIC policy cover me for using Restylane?

On December 12, 2003, Medicis received FDA approval to market Restylane in the United States. In recognition of the filler’s FDA approval status, OMIC will extend coverage to physicians who use Restylane for the correction of facial wrinkles and/or lip augmentation. OMIC also offers a sample Restylane consent form, developed by Dr. John Shore, a member of OMIC’s Underwriting and Risk Management Committees and practicing oculoplastic surgeon.

Click here for sample Consent for Restylane Injection form.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

Policyholder Services

Will my OMIC policy cover me for using Restylane?